Nivedita BHARDWAJ, Diksha CHOUDHARY, Akashdeep PATHANİA, Somesh BARANWAL, Pradeep KUMAR

Synthesis and molecular docking studies of quinoline derivatives as HIV non-nucleoside reverse transcriptase inhibitors

Quinoline moiety is an important scaffold in the field of drug discovery and drug development, with a wide range of pharmacological activities. Quinoline derivatives are potent inhibitors for reverse transcriptase, which is responsible for the conversion of single-stranded viral RNA into double-stranded viral DNA.In the present study, we have designed and synthesized 2 series, namely pyrazoline and pyrimidine containing quinoline derivatives as non nucleoside reverse transcriptase inhibitors (NNRTIs). Eleven compounds were synthesized and characterized by H-1 and C-13 NMR and mass spectrophotometry. The synthesized compounds were also docked on an HIV reverse transcriptase binding site (PDB: 412P); most of these compounds showed good binding interactions with the active domain of the receptor. Most of the compounds displayed a docking score higher than those of standard drugs. Among the synthesized quinoline derivatives, compound 4 exhibited the highest docking score (-10.675).

Keywords:

Quinoline, HIV, NNRTIs, pyrimidine, pyrazoline,

PDF

___

Bailey H, 2019, AIDS, V33, P295, DOI 10.1097/QAD.0000000000002039
Boyer J, 2011, J MED CHEM, V54, P7974, DOI 10.1021/jm200766b
Cai Y, 2018, CHEM BIOL DRUG DES, V91, P805, DOI 10.1111/cbdd.13146
Cullen MD, 2007, J MED CHEM, V50, P4854, DOI 10.1021/jm070382k
Dhakshinamoorthy A, 2010, ADV SYNTH CATAL, V352, P711, DOI 10.1002/adsc.200900747
Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o
Gaonkar SL, 2017, RES CHEM INTERMEDIAT, V43, P6043, DOI 10.1007/s11164-017-2977-5
Genin MJ, 2000, J MED CHEM, V43, P1034, DOI 10.1021/jm990383f
George A, 2018, CHEM BIOL DRUG DES, V91, P1133, DOI 10.1111/cbdd.13175
Hamama WS, 2018, RSC ADV, V8, P8484, DOI 10.1039/c7ra11537g
Hameed A, 2016, BIOORG CHEM, V65, P175, DOI 10.1016/j.bioorg.2016.02.008
Jin K, 2018, BIOORGAN MED CHEM, V12, P120
Jin KJ, 2018, EUR J MED CHEM, V145, P726, DOI 10.1016/j.ejmech.2018.01.016
Kumar S, 2018, CHEM CENT J, V12, P1 .
Kumar S, 2019, BMC CHEM, V13, DOI 10.1186/s13065-019-0601-z
Lee HY, 2018, J MED CHEM, V61, P905, DOI 10.1021/acs.jmedchem.7b01404
Lenselink EB, 2016, ACS OMEGA, V1, P293, DOI 10.1021/acsomega.6b00086
Liu WB, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00461-20
Melo BCL, 2017, J HETEROCYCLIC CHEM, V54, P3051, DOI 10.1002/jhet.2914
Nandhakumar R, 2007, EUR J MED CHEM, V42, P1128, DOI 10.1016/j.ejmech.2007.01.004
Pawar VS, 2011, MED CHEM RES, V20, P370, DOI 10.1007/s00044-010-9329-y
Prajapati DG, 2009, BIOORGAN MED CHEM, V17, P5744, DOI 10.1016/j.bmc.2009.06.060
Rao A, 2004, ANTIVIR RES, V63, P79, DOI 10.1016/j.antiviral.2004.03.004
Romeo R, 2018, MOLECULES, V24, P1718 .
Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8
Sharma V, 2016, ADV CHEM, P1, DOI [10.1155/2016/5409387, DOI 10.1155/2016/5409387]
Siddiqui ZN, 2008, MED CHEM RES, V17, P318, DOI 10.1007/s00044-007-9067-y
Simon P, 2016, EUR J MED CHEM, V122, P185, DOI 10.1016/j.ejmech.2016.06.026
Singh J, 2016, J PHARM BIOALLIED SC, V8, P188, DOI 10.4103/0975-7406.171682
Tekale AS, 2015, INT J CHEM STUD, V2, P42
Tomma JH, 2014, ARAB J CHEM, V7, P157, DOI 10.1016/j.arabjc.2013.08.024
Van den Driessche G, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0202-6
Wang L, 2018, EUR J MED CHEM, V156, P680, DOI 10.1016/j.ejmech.2018.07.035